CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

@inproceedings{Cai2015CAPIRIIMRTAP,
  title={CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer},
  author={Gang Cai and Ji Zhu and Joshua D. Palmer and Ye Xu and Wei-gang Hu and Weilie Gu and Sanjun Cai and Zhen Zhang},
  booktitle={Radiation oncology},
  year={2015}
}
BACKGROUND This study investigated the local effect and acute toxicity of irinotecan and capecitabine with concurrent intensity-modulated radiation therapy (IMRT) for the treatment of recurrent rectal cancer without prior pelvic irradiation. METHODS Seventy-one patients diagnosed with recurrent rectal cancer who did not previously receive pelvic… CONTINUE READING